ROBBIN WITKOWSKI: Open Payments
NPI 1740731827 · FOREST HILL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,348 in 114 payments from 20 companies in 2025. Trend: 2023 $2,718 · 2024 $2,930 · 2025 $2,348
Food & beverage: $2,248Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $282 |
| AstraZeneca Pharmaceuticals LP | 12 | $247 |
| GENZYME CORPORATION | 10 | $207 |
| PFIZER INC. | 9 | $173 |
| Amgen Inc. | 15 | $164 |
| ABBVIE INC. | 10 | $163 |
| Regeneron Healthcare Solutions, Inc. | 7 | $149 |
| CSL Behring | 5 | $148 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $120 |
| GlaxoSmithKline, LLC. | 5 | $116 |
Products named: DUPIXENT, TEZSPIRE, Rhapsido, NEFFY, CIBINQO, Hizentra, XOLAIR, NEMLUVIO.
Industry payments across MD — which companies pay providers there.
